Cargando…
Hydroxychloroquine‐induced erythema multiforme
Hydroxychloroquine is a commonly used medication and rarely may result in development of erythema multiforme. This potential cutaneous side effect should be highlighted in information given to patients prior to hydroxychloroquine commencement.
Autores principales: | Koumaki, Dimitra, Koumaki, Vasiliki, Bertsias, George, Boumpoucheropoulos, Sotirios, Katoulis, Alexander, Stefanidou, Maria, Miaris, Orestis, Evangelou, George, Zografaki, Kyriaki, Krueger‐Krasagakis, Sabine Elke, Krasagakis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069841/ https://www.ncbi.nlm.nih.gov/pubmed/32185066 http://dx.doi.org/10.1002/ccr3.2648 |
Ejemplares similares
-
Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia
por: Koumaki, Dimitra, et al.
Publicado: (2021) -
Pruritic annular and vesicular eruption on trunk and extremities
por: Koumaki, Dimitra, et al.
Publicado: (2020) -
An Unusual Etiology for an Acral Psoriasiform Dermatosis
por: Koumaki, Dimitra, et al.
Publicado: (2020) -
Turicella otitidis as an Unusual Agent Causing Palmoplantar Eczema: An Emerging Pathogen
por: Koumaki, Dimitra, et al.
Publicado: (2020) -
Panitumumab-Induced Eruptive Seborrhoeic Keratosis in a Patient with Metastatic Colorectal Cancer
por: Koumaki, Dimitra, et al.
Publicado: (2020)